All News
STAT+: Unpacking Trump’s latest picks for top health roles
This week in politics and public health news: Trump assembles his health care leadership team and scientist worry about a potential new travel ban.
Read MoreCDC Director Urges Focus on Health Threats as Agency Confronts Political Changes
(MedPage Today) -- The outgoing head of the nation's top public health agency urged the next administration to maintain its focus and funding to keep Americans safe from emerging health threats.
Read MoreRoche’s TIGIT troubles continue, a novel Alzheimer’s target misses the mark, and other biotech news
I spent four crazy years writing about Cassava Sciences, Adam Feuerstein writes.
Read MoreNew Amgen Drug MariTide Shows Promising Weight Loss in Early Data
The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent weight loss in a small group of patients.
Read MoreSTAT+: Pharmalittle: We’re reading about Medicare obesity drug coverage, a first-of-its-kind 340B analysis, and more
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound
Read MoreHit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer
(MedPage Today) -- HOUSTON -- Progression-free survival for 6 months (PFS6) in recurrent/progressive high-grade meningioma improved more than threefold versus historical outcomes in patients who re
Read MoreWhat 'Make America Healthy Again' Gets Right About Communications
(MedPage Today) -- Many of the nominated advisers to the incoming Trump administration challenge the American public health status quo, our health outcomes, and what influences them.
Read MoreShare your experience of buying weight loss jabs privately in the UK
We would like to hear from people who have bought weight loss jabs and the adverts they have seenWeight loss jabs like Wegovy and Mounjaro are becoming increasingly prevalent in the UK, and are availa
Read MoreEfforts To Curb ACA Enrollment Fraud Face Real-World Test
The current Affordable Care Act open enrollment season is the first big test of new federal guardrails against fraud.
Read More